Total Payments
$24,290
2024 Payments
$3,555
Companies
89
Transactions
1,217
Medicare Patients
3,222
Medicare Billing
$517,208
Payment Breakdown by Category
Food & Beverage$23,922 (98.5%)
Education$238.55 (1.0%)
Other$85.77 (0.4%)
Gifts$43.51 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,922 | 1,205 | 98.5% |
| Education | $238.55 | 5 | 1.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $85.77 | 4 | 0.4% |
| Gift | $43.51 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,333 | 144 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $1,244 | 46 | $0 (2024) |
| EMD Serono, Inc. | $1,085 | 33 | $0 (2024) |
| UCB, Inc. | $990.07 | 42 | $0 (2024) |
| Biogen, Inc. | $976.70 | 45 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $932.71 | 42 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $913.53 | 54 | $0 (2024) |
| Genentech USA, Inc. | $908.88 | 43 | $0 (2024) |
| GENZYME CORPORATION | $882.55 | 35 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $853.85 | 72 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,555 | 157 | ABBVIE INC. ($679.84) |
| 2023 | $3,675 | 154 | AbbVie Inc. ($635.56) |
| 2022 | $2,645 | 125 | ABBVIE INC. ($326.24) |
| 2021 | $3,194 | 165 | AbbVie Inc. ($332.55) |
| 2020 | $3,140 | 159 | Alexion Pharmaceuticals, Inc. ($297.58) |
| 2019 | $2,652 | 143 | Alexion Pharmaceuticals, Inc. ($270.78) |
| 2018 | $2,966 | 165 | UCB, Inc. ($280.48) |
| 2017 | $2,462 | 149 | GENZYME CORPORATION ($211.20) |
All Payment Transactions
1,217 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | SpringWorks Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.24 | General |
| 12/09/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Neuromodulation | ||||||
| 12/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.27 | General |
| Category: Neuroscience | ||||||
| 12/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Neurology | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $2.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: PAIN | ||||||
| 11/18/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $64.54 | General |
| Category: Neurology | ||||||
| 11/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Immunology | ||||||
| 11/12/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 11/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.86 | General |
| Category: NEUROLOGY | ||||||
| 11/05/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/04/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $33.88 | General |
| Category: NEUROLOGY | ||||||
| 10/31/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Analgesic | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 971 | 10,576 | $480,376 | $181,540 |
| 2022 | 9 | 713 | 1,042 | $241,016 | $95,501 |
| 2021 | 10 | 770 | 1,133 | $267,061 | $112,605 |
| 2020 | 11 | 768 | 8,671 | $330,085 | $127,562 |
Total Patients
3,222
Total Services
21,422
Medicare Billing
$517,208
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 460 | 723 | $158,337 | $60,764 | 38.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 16 | 9,200 | $92,000 | $44,964 | 48.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 109 | 143 | $42,042 | $18,811 | 44.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 80 | 80 | $24,640 | $12,963 | 52.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $21,736 | $9,462 | 43.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 61 | 124 | $23,188 | $9,122 | 39.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 22 | 39 | $27,075 | $7,391 | 27.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 37 | 37 | $20,350 | $4,688 | 23.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 14 | 38 | $38,000 | $4,408 | 11.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 22 | 22 | $14,300 | $3,397 | 23.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 48 | $10,032 | $2,907 | 29.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $6,776 | $2,189 | 32.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 12 | 12 | $1,900 | $473.98 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 447 | 731 | $160,089 | $62,087 | 38.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 98 | 98 | $24,206 | $11,926 | 49.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 63 | 73 | $21,462 | $9,741 | 45.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 22 | 40 | $7,480 | $3,132 | 41.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 18 | 18 | $5,544 | $2,861 | 51.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 11 | 11 | $7,150 | $1,826 | 25.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 35 | $7,315 | $1,694 | 23.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $4,620 | $1,345 | 29.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 20 | 21 | $3,150 | $889.25 | 28.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 454 | 748 | $163,812 | $69,834 | 42.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 104 | 104 | $25,688 | $13,221 | 51.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 53 | 60 | $17,640 | $8,366 | 47.4% |
About Dr. Charisse Barta, M.D
Dr. Charisse Barta, M.D is a Neurology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093737207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charisse Barta, M.D has received a total of $24,290 in payments from pharmaceutical and medical device companies, with $3,555 received in 2024. These payments were reported across 1,217 transactions from 89 companies. The most common payment nature is "Food and Beverage" ($23,922).
As a Medicare-enrolled provider, Barta has provided services to 3,222 Medicare beneficiaries, totaling 21,422 services with total Medicare billing of $517,208. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Plano, TX
- Active Since 07/24/2006
- Last Updated 05/11/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1093737207
Products in Payments
- BOTOX (Biological) $776.83
- UBRELVY (Drug) $772.56
- APTIOM (Drug) $768.53
- OCREVUS (Biological) $655.27
- Briviact (Drug) $614.62
- INFINITY (Device) $603.52
- TYSABRI (Biological) $572.23
- Aimovig (Biological) $561.14
- Soliris (Drug) $532.40
- NUPLAZID (Drug) $492.94
- QULIPTA (Drug) $480.94
- Gamunex-C (Biological) $480.41
- GOCOVRI (Drug) $479.65
- KESIMPTA (Drug) $477.89
- DUOPA (Drug) $464.29
- AUBAGIO (Drug) $463.56
- NUEDEXTA (Drug) $424.84
- NURTEC ODT (Drug) $415.72
- SOLIRIS (Drug) $404.01
- EMGALITY (Drug) $329.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Plano
Annette Okai, Md, MD
Neurology — Payments: $1.2M
Neurology $1.2M
Dr. Brian Sorin, M.d, M.D
Neurology — Payments: $65,471
Neurology $65,471
Parita Bhuva, M.d, M.D
Neurology — Payments: $55,398
Neurology $55,398
Dr. Wayne Bauknight, M.d, M.D
Neurology — Payments: $50,019
Neurology $50,019
Mrs. Shari Rosen Schmidt, Md, MD
Neurology — Payments: $23,989
Neurology $23,989
Dr. Obeidurahman Rehmani, M.d, M.D
Neurology — Payments: $11,980
Neurology $11,980